Patent: 7,811,560
✉ Email this page to a colleague
Summary for Patent: 7,811,560
| Title: | Compositions and methods for treating collagen-mediated diseases |
| Abstract: | A drug product comprising a combination of highly purified collagenase I and collagenase II from Colostridium histolyticum is disclosed. The drug product includes collagenase I and collagenase II in a ratio of about 1 to 1, with a purity of greater than at least 95%. The invention further disclosed improved fermentation and purification processes for preparing the said drug product. |
| Inventor(s): | Sabatino; Gregory L. (Chester Springs, PA), Del Tito, Jr.; Benjamin J. (Doylestown, PA), Bassett; Phillip J. (Newcastle-under-Lyme, GB), Tharia; Hazel A. (Nr Crewe, GB), Hitchcock; Antony G. (Crewe, GB) |
| Assignee: | Auxilium US Holdings, LLC (Wilmington, DE) |
| Application Number: | 11/699,302 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,811,560 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,811,560
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2026-01-30 |
| Auxilium Pharmaceuticals, Inc. | XIAFLEX | collagenase clostridium histolyticum | For Injection | 125338 | 02/02/2010 | ⤷ Try a Trial | 2026-01-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,811,560
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2007211313 | ⤷ Try a Trial |
| Australia | 2012200863 | ⤷ Try a Trial |
| Brazil | PI0708017 | ⤷ Try a Trial |
| Canada | 2637262 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
